Replies to post #79364 on Biotech Values

[DewDiligence]

I love the MNTA story, and I think long term they will be a big winner. But honestly don't care much for the stock. The problem with the stock is that too many small players like myself have bought in, and this makes the stock weak.

Why does that matter in the overall scheme of things? If the FDA approves the Lovenox ANDA from NVS/MNTA and does not approve the other Lovenox ANDA’s, you will have a sure 5-bagger and a possible 10-bagger (depending on whether SNY launches its own “authorized” generic). This is reason for enough for me to hold a large position, and I don’t especially care about the day-to-day price swings because I’m not a heavy user of margin.